The Art and Science of Antibody Development
Antibody development is a new trend in the field of medical science. This biotechnology provides many types of customized antibodies for use in various applications. Yes, this sounds like science fiction, but today’s technological advances allow medical researchers to custom-design antibodies that we can use to fight disease, track disease behavior, monitor disease states, screen for proteins and biochemicals and assist in drug therapies. What used to be science fiction is now fact. There is a huge world of new opportunities in the war on disease and aging because of this new biotechnology!
The new, therapeutic use of antibodies gives us tremendous promise in the fight against cancer and other diseases. For instance, on the surface of many types of cancer cells, there is an increased level of receptor proteins. These proteins make cancer cells more receptive to growth signals, which helps them to divide and spread; one of the most insidious aspects of cancer. Using customized antibodies greatly broadens our choices in treating disease. By identifying if someone has the presence of these particular proteins, we can provide more targeted and specific cancer treatments. Using these antibodies to block the receptor activity helps to prevent the growth and spread of cancer cells, and therefore, tumors. In this application, we’re using anti-receptor antibodies. This takes customized disease treatment to the next level.
glass antibodyCustom antibody development is a state-of-the-art technology that has an exciting future in immunology, cancer biology, cell biology, molecular biology and biochemistry. Developing antibodies incorporates the use of sophisticated robotics in the laboratory to separate proteins and genetic material while creating effective antibody and small-molecule drugs. It’s a superb blending of both art and science. Antibody development takes skill, knowledge and dedication. Today’s biotechnology developers recognize the need for drug therapies that work on a deeper, cellular level.
These new “antibody drugs” work on the outside of cells, where signaling sequences occur. Antibody development allows medical researchers to interfere with, or interrupt, these sequences, thereby interfering with the disease progression. Cellular communication is imperative for our health, but it’s also needed for the growth and progression of diseases, especially cancer. The exciting and remarkable thing about antibody development is that we can customize antibody drugs to target the exact process to interrupt, which can halt the disease. By using antibodies we can halt or reverse disease without harming surrounding cells and tissue. This is a major sticking point in treating all types of cancer, as well as inflammatory diseases.
Soon the use of antibody drugs will be commonplace and we’ll be able to crush the threat of cancer and degenerative, debilitating diseases, in addition to the various maladies of aging. This is the new world of biopharmaceuticals that gives disease sufferers hope and a future. In fact, it gives us all hope in our quest to be healthy while staving off age.
